AGA Nanotech News
Stay up to date with the latest news from AGA Nanotech
AGA Nanotech to Attend AMR Conference in Basel as Part of Innovate UK GBIP Switzerland
At the 9th AMR Conference, AGA Nanotech will demonstrate Battlestar™, its non-antibiotic antimicrobial solution offering sustained efficacy across critical clinical applications.
AGA Nanotech Tackles Biofilms in Bone Infections Through MSK Innovation Accelerator
Participating in a six-month programme, AGA Nanotech will advance Battlestar™ for osteomyelitis, supported by clinical and industry expertise to AMR in musculoskeletal infections.
AGA Nanotech Joins HTCC Accelerator Programme
AGA Nanotech is excited to announce our selection for the Healthcare Technologies Capabilities Connector (HTCC) SME Accelerator Programme
AGA Joins Innovate UK GBIP Sweden AMR Programme
Through this international programme, AGA Nanotech will explore AMR collaboration opportunities in Sweden, presenting Battlestar™ as a breakthrough in tackling biofilms and drug-resistant pathogens.
AGA Nanotech Awarded Best Pitch at SBC Catalyser Programme 2024
AGA Nanotech has been awarded the SBC Catalyser 2024 Award for Battlestars application in wound care. This recognition highlights our commitment to advancing infection prevention technologies.
AGA Nanotech Chosen for Prestigious Innovate UK Microbials Accelerator
AGA Nanotech is proud to announce its selection for the highly competitive Innovate UK Microbials Accelerator Programme.
AGA Nanotech Secures Major Investment to Form AGA2Tech and Combat Antimicrobial Resistance in Livestock
AGA2tech, a new venture aimed at reducing antimicrobial resistance (AMR) in livestock farming.
Combining Cold Plasma and Acetyl Donor Molecules to Fight Diabetic Foot Ulcers and Airborne Viruses
AGA Nanotech is excited to announce a groundbreaking collaboration with the University of South Australia and Lancaster University.
AGA Nanotech Awarded £1 Million UK-China Collaboration to Tackle Antimicrobial Resistance
AGA Nanotech has been awarded £1 million in funding as part of a UK-China collaboration to develop new treatments aimed at controlling the spread of antibiotic-resistant pathogens in poultry.
AGA Nanotech and UCL Business Reach Milestone Licensing Agreement for TIPS Microparticle Technology
AGA Nanotech Ltd is pleased to announce the successful conclusion of a licensing agreement with UCL Business.